These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7498296)

  • 21. d-fenfluramine's effects on normal ingestion assessed with taste reactivity measures.
    Gray RW; Cooper SJ
    Physiol Behav; 1996 Jun; 59(6):1129-35. PubMed ID: 8737903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of depletion of rat brain 5-hydroxytryptamine to alter fenfluramine-induced anorexia.
    Sugrue MF; Goodlet I; McIndewar I
    J Pharm Pharmacol; 1975 Dec; 27(12):950-3. PubMed ID: 2670
    [No Abstract]   [Full Text] [Related]  

  • 23. From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake.
    Garattini S; Mennini T; Samanin R
    Ann N Y Acad Sci; 1987; 499():156-66. PubMed ID: 2440376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of normal food intake in rats and dogs and inhibition of experimentally induced hyperphagia in rats by CM 57373 and fenfluramine.
    Miranda GF; Poggesi E; Bianchetti A; Unkovic J; Samanin R
    Eur J Pharmacol; 1988 May; 150(1-2):155-61. PubMed ID: 2456940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic anorexic and behavioural effects of the fenfluramine metabolite, norfenfluramine: an evaluation of its role in the actions of fenfluramine.
    Goudie AJ; Taylor M; Wheeler TJ
    Psychopharmacologia; 1974; 38(1):67-74. PubMed ID: 4851021
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of chronic administration of fenfluramine and quipazine on body weight gain after ovariectomy and on brain serotonin receptor binding.
    Rowland N; Carlton J; Bartness T; Smith G
    Behav Neurosci; 1983 Jun; 97(3):502-5. PubMed ID: 6683563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fenfluramine acts as a positive modulator of sigma-1 receptors.
    Martin P; de Witte PAM; Maurice T; Gammaitoni A; Farfel G; Galer B
    Epilepsy Behav; 2020 Apr; 105():106989. PubMed ID: 32169824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does increased endogenous CCK interact with serotonin to reduce food intake in rats?
    Voigt JP; Wenz D; Voits M; Fink H
    Peptides; 2000 Dec; 21(12):1895-901. PubMed ID: 11150652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Weight cycling alters the effects of D-fenfluramine on susceptibility to activity-based anorexia.
    Rieg TS; Maestrello AM; Aravich PF
    Am J Clin Nutr; 1994 Oct; 60(4):494-500. PubMed ID: 8092083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS; Schuster CR; Seiden LS
    J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine.
    Rowland NE; Marshall M; Robertson K
    Eur J Pharmacol; 2001 May; 419(1):61-4. PubMed ID: 11348631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD; Yuan J; Ricaurte GA
    Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability.
    Curzon G; Gibson EL; Oluyomi AO
    Trends Pharmacol Sci; 1997 Jan; 18(1):21-5. PubMed ID: 9114726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel agents affecting eating through an action on monoaminergic systems.
    Roncucci R; Miranda GF; Verry M
    Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic anorectic effect of dehydroepiandrosterone and d-Fenfluramine on the obese Zucker rat.
    Gillen G; Porter JR; Svec F
    Physiol Behav; 1999 Aug; 67(2):173-9. PubMed ID: 10477047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance to the anorectic effect of dexfenfluramine in rats: role of serotonin, cholecystokinin, and neuropeptide Y.
    Rowland NE
    Physiol Behav; 1994 Feb; 55(2):201-7. PubMed ID: 8153156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fenfluramine in man: hypophagia associated with diminished serotonin turnover.
    Shoulson I; Chase TN
    Clin Pharmacol Ther; 1975 May; 17(5):616-21. PubMed ID: 1092516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic lesions and drug-induced anorexia.
    Blundell JE; Leshem MB
    Postgrad Med J; 1975; 51 Suppl 1():45-54. PubMed ID: 1219679
    [No Abstract]   [Full Text] [Related]  

  • 40. Serotonergic mediation of fenfluramine discriminative stimuli in fawn-hooded rats.
    Schechter MD
    Life Sci; 1997; 60(6):PL83-90. PubMed ID: 9031690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.